H.736 is a bill introduced by several representatives that addresses the challenges faced by inpatient health care facilities in providing necessary medications for patients with rare diseases. The bill highlights the insufficient stock of these medications and the difficulties in procuring them promptly for patients who are already on treatment regimens upon admission. To improve medication adherence and ensure continuity of care, the bill mandates that health care facilities must allow patients in inpatient status to continue taking all medically necessary medications prescribed by their licensed health care providers, regardless of whether the facility typically dispenses those medications.

This legislation aims to enhance patient care by ensuring that individuals with rare diseases can maintain their treatment plans without interruption during their hospital stay. By allowing the continuation of prescribed medications, the bill seeks to improve health outcomes and streamline the care process for patients who may otherwise face challenges in managing their conditions while hospitalized.